Labeler · US market
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. is a US drug labeler with US FDA registrations covering 3 drug concepts (3 currently active) across 17 packages. It is currently the only active US supplier of 3 drugs.
ACTIVE - US
openFDA · updated weekly
Labeler codes71881 · 73562
Active drugs3
Registrations11 active / 11
Packages17
Sole supplier of3 drugs
No company profile yet
FDA filings tell us what Aimmune Therapeutics, Inc. registers, not who it is. If you know this company - what it makes, who owns it, where it manufactures - you can add it. Every submission is reviewed before it goes live.
Submit information about this company →Portfolio3 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Pancrelipase Lipase, Pancrelipase Protease, Pancrelipase Amylase capsule, delayed release | rx | 8 | 14 | SUPPLYING |
| Pancrelipase tablet | rx | 2 | 2 | SUPPLYING |
| Fecal Microbiota Spores, Live-Brpk capsule | rx | 1 | 1 |